Facebook tracking pixelCandida Dermatitis - AI-Powered ICD-10 Documentation
B37.2
ICD-10-CM
Candida Dermatitis

Candida dermatitis, also known as yeast infection of the skin or candidal intertrigo, diagnosis information for healthcare professionals. Learn about clinical documentation, medical coding, ICD-10 codes for Candida dermatitis, and best practices for diagnosing and treating this skin condition. Find resources for accurate and efficient healthcare documentation related to Candida infections.

Also known as

Yeast Infection of the Skin
Candidal Intertrigo

Diagnosis Snapshot

Key Facts
  • Definition : Fungal skin infection caused by Candida species, often in warm, moist areas.
  • Clinical Signs : Red, itchy rash with satellite lesions, sometimes with white pustules or scaling.
  • Common Settings : Skin folds (groin, armpits, under breasts), diaper area, oral mucosa.

Related ICD-10 Code Ranges

Complete code families applicable to AAPC B37.2 Coding
B37.2

Candidiasis of skin and nails

Fungal skin infection caused by Candida species.

L30.9

Dermatitis, unspecified

Inflammation of the skin without specific cause.

L29.9

Pruritus, unspecified

Itching of the skin with no identified underlying cause.

Code-Specific Guidance

Decision Tree for

Follow this step-by-step guide to choose the correct ICD-10 code.

Is the Candida dermatitis diaper-related?

  • Yes

    Code B37.81, Candidiasis of the skin and mucous membrane, diaper region

  • No

    Is there intertrigo?

Code Comparison

Related Codes Comparison

When to use each related code

Description
Yeast skin infection causing redness, itching.
Fungal skin infection, ring-shaped rash.
Skin inflammation from moisture, friction.

Documentation Best Practices

Documentation Checklist
  • Document affected skin areas (e.g., intertriginous folds)
  • Describe lesion morphology (e.g., erythema, satellite pustules)
  • Note presence of itching, burning, or pain
  • Document KOH prep results if performed
  • Record patient's risk factors (e.g., obesity, diabetes)

Coding and Audit Risks

Common Risks
  • Unspecified Site

    Coding Candida dermatitis without specifying the affected body area can lead to claim rejections and inaccurate data.

  • Clinical Validation

    Lack of proper documentation supporting the Candida diagnosis can cause audit failures and compliance issues.

  • Diabetic Complications

    Failing to code associated diabetes when present with Candida dermatitis may impact risk adjustment and reimbursement.

Mitigation Tips

Best Practices
  • Keep skin clean and dry. ICD-10-CM: B37.8, B37.9
  • Avoid tight clothing, opt for breathable fabrics. SNOMED CT: 48726009
  • Treat affected area with antifungal creams/powders as prescribed. RxNorm: 825147
  • Manage underlying conditions like diabetes. ICD-10-CM: E11.9
  • Good hygiene practices crucial for prevention. LOINC: 72166-2

Clinical Decision Support

Checklist
  • Confirm skin erythema, scaling, satellite lesions in intertriginous areas.
  • Document KOH prep or culture showing yeast/pseudohyphae.
  • Rule out differential diagnoses: eczema, psoriasis, contact dermatitis.
  • Assess patient risk factors: obesity, diabetes, antibiotic use.

Reimbursement and Quality Metrics

Impact Summary
  • Candida Dermatitis (C) reimbursement hinges on accurate ICD-10 coding (B37.-) and supporting documentation for medical necessity.
  • Coding quality impacts Candida Dermatitis claims. Correctly specifying infection site (e.g., B37.1, B37.2) maximizes reimbursement.
  • Hospital reporting of Candida Dermatitis cases influences infection control metrics and resource allocation. Accurate diagnosis coding is crucial.
  • Misdiagnosis or unspecified Candida (B37.9) may lead to claim denials, impacting hospital revenue and quality performance.

Streamline Your Medical Coding

Let S10.AI help you select the most accurate ICD-10 codes for . Our AI-powered assistant ensures compliance and reduces coding errors.

Frequently Asked Questions

Common Questions and Answers

Q: How to differentiate Candida dermatitis from other intertriginous rashes in clinical practice?

A: Differentiating Candida dermatitis, also known as yeast infection of the skin or candidal intertrigo, from other intertriginous rashes requires careful clinical evaluation. While satellite lesions and a beefy-red appearance with well-defined borders are characteristic of Candida, consider the following: 1. Evaluate for scaling and maceration, common in Candida but also seen in other fungal infections like tinea cruris. 2. Obtain a KOH preparation to confirm the presence of yeast and rule out dermatophytes. 3. Assess patient history, including risk factors like diabetes, obesity, and antibiotic use, which predispose to Candida. 4. Consider bacterial culture to rule out secondary bacterial infection, common in intertriginous areas. 5. Explore how different topical antifungals, such as nystatin, clotrimazole, and ketoconazole, compare in efficacy and patient tolerability for candidal intertrigo. Remember, other conditions like inverse psoriasis, contact dermatitis, and erythrasma can mimic Candida dermatitis, necessitating a comprehensive differential diagnosis. Explore our in-depth guide on managing intertriginous rashes for a detailed approach.

Q: What are the best topical treatment options for Candida dermatitis in obese patients, considering skin folds and moisture?

A: Treating Candida dermatitis, also known as a yeast infection of the skin, in obese patients presents unique challenges due to increased skin folds and moisture retention. Powders like nystatin or miconazole can be helpful in absorbing moisture and preventing friction, but consider their potential for caking and discomfort. Creams and ointments containing antifungals like clotrimazole, ketoconazole, or econazole are effective but may require more frequent application due to dilution from perspiration. Consider implementing strategies to keep the affected areas dry, such as using absorbent powders and loose-fitting clothing. For persistent or severe cases, systemic antifungal therapy like fluconazole may be necessary. Learn more about the role of weight management and hygiene practices in preventing recurrent Candida dermatitis in obese patients.

Quick Tips

Practical Coding Tips
  • Code B37.8 for candidiasis
  • Document skin folds,lesions
  • Rule out diaper rash in infants
  • Consider comorbidities like diabetes
  • Confirm with KOH microscopy if needed

Documentation Templates

Patient presents with clinical manifestations consistent with Candida dermatitis, also known as a yeast infection of the skin or candidal intertrigo.  The affected area, located in [Location - e.g., the inguinal folds], exhibits erythema, satellite lesions, and maceration.  The patient reports [Symptom - e.g., pruritus and burning sensation] in the affected area.  Differential diagnoses considered include intertrigo, contact dermatitis, and seborrheic dermatitis.  Based on the patient's presentation and the characteristic appearance of the rash, a clinical diagnosis of Candida dermatitis is made.  Microscopic examination with potassium hydroxide (KOH) preparation may be performed to confirm the diagnosis.  Treatment plan includes topical antifungal therapy with [Medication - e.g., clotrimazole cream] applied to the affected area twice daily for [Duration - e.g., two weeks].  Patient education provided on proper hygiene practices, including keeping the area clean and dry, and avoiding tight-fitting clothing.  Follow-up appointment scheduled in [Duration - e.g., two weeks] to assess treatment response and adjust management as needed.  ICD-10 code B37.2 (Candidiasis of skin and nails) is documented for billing purposes.